RECENT NEWS

Sakura Finetek Europe and MEDIPATH, a group of independent French pathologists, are to collaborate to enhance cancer diagnostics and improve conditions for cancer patients.

Digital pathology provider Indica Labs has announced that the Institute of Tissue Medicine and Pathology at the University of Bern, a leading university-based pathology institute in Switzerland, has selected HALO AP for the Institute’s first-in-country digital pathology deployment in the cloud powered by Amazon Web Services, Inc. (AWS).

Lunit, a provider of AI-powered solutions for cancer diagnostics and therapeutics, has announced the publication of a new study detailing the development of its Universal Immunohistochemistry (uIHC) AI model.

A research team led by the University of Liverpool has developed an innovative new technique that can rapidly assess paracetamol levels from saliva.

ZEISS partners with Mindpeak, a pioneer in AI-powered pathology solutions, to develop an integrated multiplex immunofluorescence (mIF) solution that serves pathologists across research, diagnostics, and clinical applications.

AI biotech company Owkin has launched its latest report, ‘State of the Nation: Opportunities and Challenges for Digital Pathology and AI Solutions’, exploring the evolving landscape of digital pathology and AI in healthcare across the United States, United Kingdom, and France.

A specialist team created to rapidly boost the country’s ability to diagnose and test for new and emerging infectious disease threats has been launched by the UK Health Security Agency (UKHSA), strengthening the UK’s pandemic preparedness and response.

The Medical Research Council is launching its first two Centres of Research Excellence, which will develop transformative new genomic therapeutics for currently untreatable diseases.

WASP Software, together with Warrington & Halton Teaching Hospitals NHS Foundation Trust, has been shortlisted for the Best Technology Partnership of the Year category at the HSJ Partnership Awards 2025 for a transformation project that has resulted in paperless phlebotomy booking services.

Sphere Fluidics, a leading provider of innovative microfluidics-based solutions for single-cell analysis and isolation, has announced the launch of Cyto-Cellect Fc Fusion, a novel assay designed to accelerate cell line development for Fc fusion manufacturing.

A tiny, four-fingered ‘hand’ folded from a single piece of DNA can pick up the virus that causes COVID-19 for highly sensitive rapid detection and can even block viral particles from entering cells to infect them, University of Illinois Urbana-Champaign researchers report in a new study.

Cambridge scientists have developed a urine test for early detection of lung cancer. The test, the first of its kind, detects 'zombie' cells that could indicate the first signs of the disease.

The Microbiology Society has coordinated a response to the consultation launched by the government and NHS England ahead of the 10-Year Plan.

The government and NHS will unveil a refreshed workforce plan in the summer with a focus on shifting care from hospitals and into the community, as work to support NHS recovery continues.

The Future Medicines Institute based at Queen’s University Belfast has received £55 million funding aimed at advancing the precision medicine sector. Managed by UK Research and Innovation’s Strength in Places Fund, the Institute is backed by a consortium of medical companies.

The Royal College of Pathologists' submission to the government's 10-Year Health Plan for England calls for urgent investment in the pathology workforce, IT, and estates.

NHS fears of a potential ‘quad-demic’ are rising with a 350% increase in influenza cases and an 86% rise in norovirus cases in hospital compared to same week last year – alongside concerns about rising COVID-19 and respiratory syncytial virus (RSV) levels in hospitals.

Five innovative technologies have been selected by the Medicines and Healthcare products Regulatory Agency (MHRA) for the AI Airlock, a pilot scheme to better understand how we can regulate artificial intelligence (AI) powered medical devices.

Beckman Coulter Life Sciences has launched the Cydem VT Automated Clone Screening System, a revolutionary high-throughput microbioreactor platform for automated top clone screening.

Diagnostics firm Prolight’s novel point-of-care Psyros system has reached the prototype stage, the company has announced.